Optiver Holding B.V. Gilead Sciences, Inc. Transaction History

Optiver Holding B.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $1,465 - $1,661	20 Added 400.0%	25 $2,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $369 - $403	5 New	5 $0
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $3,924 - $4,420	-68 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $7,761 - $9,725	-134 Reduced 66.34%	68 $4,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $3,049 - $3,461	47 Added 30.32%	202 $14,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $12,658 - $13,656	-187 Reduced 54.68%	155 $11,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $8.73 Million - $9.54 Million	-137,579 Reduced 99.75%	342 $24,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $8.28 Million - $9.44 Million	137,921 New	137,921 $8.91 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.